The past year has seen significant change for the UK commercial office investment market. A combination of factors, both international and domestic, has contributed to fluctuation in the sector and 2019 is forecast to be an eventful – but potentially very fruitful – year for those who have the appetite and resources to adapt.
Even though the UK has now implemented the General Data Protection Regulation (GDPR), it’ll need to agree new arrangements with the EU post-Brexit.
Until recently, ethical investing was seen as an expensive fad, sacrificing returns for principles. However, the fad has not gone away. In fact, it seems to be gaining in validity and attracting increasing amounts of investment capital.
The European Commission has consistently advocated against intra-EU bilateral investment treaties (BITs).
UK limited partnership law reforms are like buses: you wait ages, then lots arrive at once. The legislation is over 100 years old and in the last few years, notable changes have been made.
Wags have predicted consolidation fever in the asset management space for a good half-decade, but few seem to have looked back at whether history followed the tarot cards.
For those asset managers’ legal and compliance teams who breathed a sigh of relief in January when MiFID II was implemented, the next items on the UK regulatory change agenda probably include the Financial Conduct Authority’s Asset Management Market Study (AMMS), the Senior Managers and Certification Regime (SM&CR) and responding to Brexit.
The European funds industry, like the rest of the financial services industry and indeed many other industries, is awaiting a clear path forward in the post-Brexit environment.
The UK’s residential income investment market is changing rapidly with increased political focus, leasehold reform, new entrants and insatiable housing demand.
Few in financial services will have missed the advent of MiFID II. So intense was the interest, it would have been easy to overlook the EU Benchmarks Regulation, which will also have significant implications for the buy-side in 2018.
